Non-myeloablative conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia. The impact of the remission status
Multicentre randomized trials have shown that allogeneic hematopoietic stem cell transplantation (HSCT) is the most effective strategy for preventing relapse in patients in first complete remission (CR) of acute myeloblastic leukemia (AML), offering up to 50% disease-free survival. However in adult...
Autores principales: | , , , , , , |
---|---|
Formato: | Artículo |
Lenguaje: | inglés |
Publicado: |
2005
|
Materias: | |
Acceso en línea: | http://eprints.uanl.mx/27802/1/492.pdf |
_version_ | 1824420827097989120 |
---|---|
author | Gutiérrez Aguirre, César Homero Cantú Rodríguez, Olga Graciela González Llano, Óscar Salazar Riojas, R. Martínez González, Odra Lizzette Jaime Pérez, José Carlos Gómez Almaguer, David |
author_facet | Gutiérrez Aguirre, César Homero Cantú Rodríguez, Olga Graciela González Llano, Óscar Salazar Riojas, R. Martínez González, Odra Lizzette Jaime Pérez, José Carlos Gómez Almaguer, David |
author_sort | Gutiérrez Aguirre, César Homero |
collection | Repositorio Institucional |
description | Multicentre randomized trials have shown that allogeneic hematopoietic stem cell transplantation (HSCT) is the most effective strategy for preventing relapse in patients in first complete remission (CR) of acute myeloblastic leukemia (AML), offering up to 50% disease-free survival. However in adult patients with good risk AML, allogeneic HSCT is usually indicated in second complete remission or first untreated relapse. We analyzed the outcome of 16 AML patients who received a reduced intensity conditioning regimen for allogeneic HSCT in first or second remission. |
format | Article |
id | eprints-27802 |
institution | UANL |
language | English |
publishDate | 2005 |
record_format | eprints |
spelling | eprints-278022024-12-09T17:50:40Z http://eprints.uanl.mx/27802/ Non-myeloablative conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia. The impact of the remission status Gutiérrez Aguirre, César Homero Cantú Rodríguez, Olga Graciela González Llano, Óscar Salazar Riojas, R. Martínez González, Odra Lizzette Jaime Pérez, José Carlos Gómez Almaguer, David RD Cirugía Multicentre randomized trials have shown that allogeneic hematopoietic stem cell transplantation (HSCT) is the most effective strategy for preventing relapse in patients in first complete remission (CR) of acute myeloblastic leukemia (AML), offering up to 50% disease-free survival. However in adult patients with good risk AML, allogeneic HSCT is usually indicated in second complete remission or first untreated relapse. We analyzed the outcome of 16 AML patients who received a reduced intensity conditioning regimen for allogeneic HSCT in first or second remission. 2005 Article PeerReviewed text en http://eprints.uanl.mx/27802/1/492.pdf http://eprints.uanl.mx/27802/1.haspreviewThumbnailVersion/492.pdf Gutiérrez Aguirre, César Homero y Cantú Rodríguez, Olga Graciela y González Llano, Óscar y Salazar Riojas, R. y Martínez González, Odra Lizzette y Jaime Pérez, José Carlos y Gómez Almaguer, David (2005) Non-myeloablative conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia. The impact of the remission status. Biology of Blood and Marrow Transplantation, 11 (2). pp. 61-62. ISSN 10838791 http://doi.org/10.1016/j.bbmt.2004.12.184 doi:10.1016/j.bbmt.2004.12.184 |
spellingShingle | RD Cirugía Gutiérrez Aguirre, César Homero Cantú Rodríguez, Olga Graciela González Llano, Óscar Salazar Riojas, R. Martínez González, Odra Lizzette Jaime Pérez, José Carlos Gómez Almaguer, David Non-myeloablative conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia. The impact of the remission status |
thumbnail | https://rediab.uanl.mx/themes/sandal5/images/online.png |
title | Non-myeloablative conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia. The impact of the remission status |
title_full | Non-myeloablative conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia. The impact of the remission status |
title_fullStr | Non-myeloablative conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia. The impact of the remission status |
title_full_unstemmed | Non-myeloablative conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia. The impact of the remission status |
title_short | Non-myeloablative conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia. The impact of the remission status |
title_sort | non myeloablative conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia the impact of the remission status |
topic | RD Cirugía |
url | http://eprints.uanl.mx/27802/1/492.pdf |
work_keys_str_mv | AT gutierrezaguirrecesarhomero nonmyeloablativeconditioningforallogeneichematopoieticstemcelltransplantationinpatientswithacutemyeloidleukemiatheimpactoftheremissionstatus AT canturodriguezolgagraciela nonmyeloablativeconditioningforallogeneichematopoieticstemcelltransplantationinpatientswithacutemyeloidleukemiatheimpactoftheremissionstatus AT gonzalezllanooscar nonmyeloablativeconditioningforallogeneichematopoieticstemcelltransplantationinpatientswithacutemyeloidleukemiatheimpactoftheremissionstatus AT salazarriojasr nonmyeloablativeconditioningforallogeneichematopoieticstemcelltransplantationinpatientswithacutemyeloidleukemiatheimpactoftheremissionstatus AT martinezgonzalezodralizzette nonmyeloablativeconditioningforallogeneichematopoieticstemcelltransplantationinpatientswithacutemyeloidleukemiatheimpactoftheremissionstatus AT jaimeperezjosecarlos nonmyeloablativeconditioningforallogeneichematopoieticstemcelltransplantationinpatientswithacutemyeloidleukemiatheimpactoftheremissionstatus AT gomezalmaguerdavid nonmyeloablativeconditioningforallogeneichematopoieticstemcelltransplantationinpatientswithacutemyeloidleukemiatheimpactoftheremissionstatus |